Related Experiment Video
Updated: Aug 6, 2026

Stress-induced Antibiotic Susceptibility Testing on a Chip
Published on: January 8, 2014
Statin-induced lipid carrier stress reveals a conserved vulnerability in β-lactam-resistant Gram-positive bacteria
Gabriel Torrens1, Sean W Bisset1, Maria López-Bravo2
1Department of Molecular Biology, Umeå University, Umeå, Sweden.
Abstract:
Methicillin-resistant Staphylococcus aureus resists β-lactam antibiotics through the allosteric transpeptidase penicillin-binding protein 2a, which operates within staphyloxanthin-rich membrane microdomains. Statins restore susceptibility by disrupting these microdomains and impairing penicillin-binding protein 2a oligomerization, but the mechanisms enabling resistance to this resensitization remain unclear. Here we show, using evolution experiments in strains lacking a functional staphyloxanthin pathway, that mutations in gdpP, a regulator of cyclic di-adenosine monophosphate signaling, are the predominant route for restoring oxacillin resistance during membrane microdomain disruption. This adaptation is blocked by simvastatin, revealing a synthetic lethal interaction. Mechanistically, simvastatin inhibits the mevalonate pathway, depleting the essential lipid carrier undecaprenyl phosphate and exacerbating peptidoglycan precursor imbalance, an effect phenocopied by lipid carrier-targeting antibiotics such as bacitracin. Although compensatory mutations can restore resistance, they impose a fitness cost in vivo. Importantly, this vulnerability extends to Streptococcus pneumoniae, revealing a conserved strategy to overcome β-lactam resistance in Gram-positive pathogens.
Insights
New research reveals how bacteria like MRSA develop resistance to antibiotics. Mutations in a specific gene, gdpP, allow bacteria to regain resistance when statins disrupt their membranes, offering new targets for drug development.
Area of Science:
- Microbiology
- Drug Discovery
- Molecular Biology
Background:
- Methicillin-resistant Staphylococcus aureus (MRSA) employs penicillin-binding protein 2a (PBP2a) within membrane microdomains to resist beta-lactam antibiotics.
- Statins can resensitize MRSA to beta-lactams by disrupting these microdomains and PBP2a oligomerization.
- The mechanisms by which bacteria develop resistance to statin-mediated resensitization are not fully understood.
Purpose of the Study:
- To elucidate the mechanisms of resistance to statin-mediated resensitization in MRSA.
- To identify genetic adaptations that restore oxacillin resistance during membrane microdomain disruption.
- To explore potential conserved vulnerabilities in Gram-positive pathogens.
Main Methods:
- Conducted evolution experiments with MRSA strains lacking a functional staphyloxanthin pathway.
- Utilized simvastatin to investigate its effect on resistance acquisition.
- Employed genetic analysis to identify mutations conferring resistance.
- Investigated the role of cyclic di-adenosine monophosphate (c-di-AMP) signaling.
- Assessed the impact of mevalonate pathway inhibition and lipid carrier depletion.
- Tested the vulnerability in Streptococcus pneumoniae.
Main Results:
- Mutations in gdpP, a regulator of cyclic di-adenosine monophosphate (c-di-AMP) signaling, were the primary mechanism for restoring oxacillin resistance.
- Simvastatin treatment blocked this adaptation, indicating a synthetic lethal interaction.
- Simvastatin's inhibition of the mevalonate pathway depleted undecaprenyl phosphate, causing peptidoglycan precursor imbalance.
- This imbalance effect was mimicked by bacitracin, a lipid carrier-targeting antibiotic.
- Compensatory mutations conferring resistance resulted in a fitness cost in vivo.
- The identified vulnerability was conserved in Streptococcus pneumoniae.
Conclusions:
- Bacterial adaptation to statin-induced membrane disruption predominantly occurs through mutations in gdpP, affecting c-di-AMP signaling.
- Simvastatin reveals a synthetic lethal interaction by targeting the mevalonate pathway, leading to essential lipid depletion and peptidoglycan precursor imbalance.
- This conserved vulnerability in Gram-positive pathogens, including S. pneumoniae, offers a potential strategy to overcome beta-lactam resistance.
More Related Videos
08:19Generating Transposon Insertion Libraries in Gram-Negative Bacteria for High-Throughput Sequencing
Published on: July 7, 2020
11:59Isolation of Lipoprotein Particles from Chicken Egg Yolk for the Study of Bacterial Pathogen Fatty Acid Incorporation into Membrane Phospholipids
Published on: May 15, 2019
Related Concept Videos
Clinical Significance of Antibiotic Resistance
Inhibitors of Gram-positive Cell Wall Synthesis
Development of Antibiotic Resistance
Mechanism of Antibiotic Resistance in MRSA
Inhibitors of Bacterial Protein Synthesis
Other Stress Responses in Bacteria